Skip to content

A prospective single arm study evaluating the effectiveness and safety of breast patches for soft tissue enhancement during breast reconstruction surgery

A prospective single arm study evaluating the effectiveness and safety of breast patches for soft tissue enhancement during breast reconstruction surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092746
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast reconstruction surgery

Interventions

Sponsors

Fudan University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged >=18 years old; 2. Patients with unilateral breast cancer, and the maximum diameter of the tumor is <= 5cm; 3. Clinical axillary lymph node (ALN) negative (clinical physical examination and ultrasound revealed negative axillary lymph nodes; clinically suspicious axillary lymph nodes, fine needle aspiration or core needle biopsy results are negative); 4. Patients who intend to undergo mastectomy (SSM/NSM) with skin or nipple and areola preserving and need to use prosthesis and patch for immediate breast reconstruction; 5. No smoking history or quit smoking for more than 4 weeks (inclusive); 6. After obtaining full knowledge, voluntarily participate and sign the "Informed Consent".

Exclusion criteria

Exclusion criteria: 1. Patients with moderate to severe breast sagging; 2. Patients who have received radiotherapy at the reconstruction site or chest wall and/or are expected to undergo radiotherapy after surgery; 3. Patients who have received neoadjuvant therapy; 4. Plan to perform symmetrical breast surgery on the healthy side of the breast during the visit period; 5. Expected implanted breast prosthesis volume> 500ml; 6. Suffer from poorly controlled diabetes, severe heart disease, heart failure or severe liver and kidney dysfunction/blood system diseases and other serious systemic diseases; 7. People with mental illness or mental abnormality; 8. Patients who are pregnant, breastfeeding or planning to conceive during the study period; 9. Participating in other clinical trials, which may affect participation in this trial; 10. Poor compliance, unable to carry out relevant inspections and follow-ups in accordance with the test requirements; 11. Other patients who have been judged by the investigator to be unsuitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Breast reconstruction success rate;

Secondary

MeasureTime frame
Complications;Breast-Q (breast reconstruction module) score changes;Evaluation of Aesthetic Effect of Breast Reconstruction;

Countries

China

Contacts

Public ContactWu Jiong

Fudan University Cancer Hospital

wujiong1122@vip.sina.com+86 136 0163 7369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026